3 For recent reviews, see: (a) K. Mikami, Y. Itoh and M. Yamanaka,
Chem. Rev., 2004, 104, 1; (b) J.-A. Ma and D. Cahard, Chem. Rev.,
2004, 104, 6119; (c) M. Oestreich, Angew. Chem., Int. Ed., 2005, 44,
2324; (d) G. K. S. Prakash and P. Beier, Angew. Chem., Int. Ed.,
2006, 45, 2172; (e) P. M. Pihko, Angew. Chem., Int. Ed., 2006, 45,
544; (f) H. Ibrahim and A. Togni, Chem. Commun., 2004, 1147;
(g) V. A. Brunet and D. O’Hagan, Angew. Chem., Int. Ed., 2007,
46, 1179; (h) R. Smits, C. D. Cadicamo, K. Burger and B. Koksch,
Chem. Soc. Rev., 2008, 37, 1727.
4 (a) J. Christoffers and A. Mann, Angew. Chem., Int. Ed., 2001, 40,
4591; (b) I. Denissova and L. Barriault, Tetrahedron, 2003, 59,
10105; (c) J. Christoffers and A. Baro, Adv. Synth. Catal., 2005,
347, 1473; (d) O. Riant and J. Hannedouche, Org. Biomol. Chem.,
2007, 5, 873; (e) P. G. Cozzi, R. Hilgraf and N. Zimmermann, Eur.
J. Org. Chem., 2007, 5969.
Fig. 2 X-Ray crystallographic structure of 3n.
5 (a) L. Hintermann and A. Togni, Angew. Chem., Int. Ed., 2000, 39,
4359; (b) S. Piana, I. Devillers, A. Togni and U. Rothlisberger,
Angew. Chem., Int. Ed., 2002, 41, 979; (c) Y. Hamashima, K. Yagi,
H. Takano, L. Tamas and M. Sodeoka, J. Am. Chem. Soc., 2002,
124, 14530; (d) Y. Hamashima, T. Suzuki, H. Takano, Y. Shimura
and M. Sodeoka, J. Am. Chem. Soc., 2005, 127, 10164;
(e) N. Shibata, J. Kohno, K. Takai, T. Ishimaru, S. Nakamura,
T. Toru and S. Kanemasa, Angew. Chem., Int. Ed., 2005, 44, 4204;
(f) M. Nakamura, A. Hajra, K. Endo and E. Nakamura, Angew.
Chem., Int. Ed., 2005, 44, 7248; (g) D. S. Reddy, N. Shibata,
J. Nagai, S. Nakamura, T. Toru and S. Kanemasa, Angew. Chem.,
Int. Ed., 2008, 47, 164.
product 3n in 98% yield and 86% ee. The absolute stereo-
configuration of the products was determined by single-crystal
X-ray structural analysis based on the product 3n (Fig. 2).13
In an exploratory study, we demonstrated that product 3c
can be conveniently converted to synthetically useful chiral
D1-pyrrolidine 4 by RANEYs-Ni mediated hydrogenation
with high efficiency (Scheme 1).14
6 (a) D. Enders and M. R. M. Huttl, Synlett, 2005, 991;
(b) D. D. Steiner, N. Mase and C. F. Barbas III, Angew. Chem.,
Int. Ed., 2005, 44, 3706; (c) M. Marigo, D. Fielenbach,
A. Braunton, A. Kjoersgaard and K. A. Jørgensen, Angew. Chem.,
Int. Ed., 2005, 44, 3703; (d) T. D. Beeson and D. W. C. MacMillan,
J. Am. Chem. Soc., 2005, 127, 8826.
7 S. Brandes, B. Niess, M. Bella, A. Prieto, J. Overgaard and
K. A. Jørgensen, Chem.–Eur. J., 2006, 12, 6039.
Scheme 1 Transformation of 3c to chiral D1-pyrrolidine 4.
8 T. Ishimaru, N. Shibata, T. Horikawa, N. Yasuda, S. Nakamura,
T. Toru and M. Shiro, Angew. Chem., Int. Ed., 2008, 47,
4157.
In conclusion, we have uncovered an unprecedented organo-
catalytic, enantioselective conjugate addition reaction of
a-fluoroketoester and nitroolefins. The process is efficiently
catalyzed by a readily available chiral cinchona alkaloid
derivative using as low as 1 mol%. Significantly, a fluorine
containing quaternary carbon center and an adjacent chiral
carbon center are created with an excellent level of enantio-
selectivity and in high yields in the conjugate addition process.
In principle, the strategy we have described can be extended to
other fluorinated nucleophilic reagents and Michael receptors.
This constitutes our future direction aimed at expanding
the scope of powerful organocatalytic processes for the
asymmetric synthesis of fluorine containing compounds.
Financial support for this work provided by the NSF
(CHE-0704015) is gratefully acknowledged. Thanks are
expressed to Dr Elieen N. Duesler for performing X-ray
analysis. The Bruker X8 X-ray diffractometer was purchased
via an NSF CRIF:MU award to the University of New
Mexico, CHE-0443580.
9 D. Y. Kim and E. J. Park, Org. Lett., 2002, 4, 545.
10 For selected examples using ketoesters as nucleophiles for
conjugate addition reactions, see: (a) H. Li, Y. Wang, L. Tang,
F. Wu, X. Liu, C. Guo, B. M. Foxman and L. Deng, Angew.
Chem., Int. Ed., 2005, 44, 105; (b) T. Okino, Y. Hoashi,
T. Furukawa, X. Xu and Y. Takemoto, J. Am. Chem. Soc.,
2005, 127, 119; (c) J. Wang, H. Li, L.-S. Zu, W. Jiang,
H.-X. Xie, W.-H. Duan and W. Wang, J. Am. Chem. Soc.,
2006, 128, 12652; (d) T. B. Poulsen, L. Bernardi, J. Aleman,
J. Overgaard and K. A. Jørgensen, J. Am. Chem. Soc., 2007,
129, 441.
11 See an example of non-enolizable ketoesters in the synthesis of
PDE4 inhibitor IC86518: P. J. Nichols, J. A. DeMattei,
B. R. Barnett, N. A. LeFur, T.-H. Chuang, A. D. Piscopio and
K. Koch, Org. Lett., 2006, 8, 1495.
12 Recent reviews of hydrogen-bond mediated catalysis, see:
(a) P. R. Schreiner, Chem. Soc. Rev., 2003, 32, 289;
(b) S.-K. Tian, Y.-G. Chen, J.-F. Hang, L. Tang, P. McDaid and
L. Deng, Acc. Chem. Res., 2004, 37, 621; (c) Y. Takemoto, Org.
Biomol. Chem., 2005, 3, 4299; (d) T. Akiyama, J. Itoh and
K. Fuchibe, Adv. Synth. Catal., 2006, 348, 999; (e) M. S. Taylor
and E. N. Jacobsen, Angew. Chem., Int. Ed., 2006, 45, 1520;
(f) S. J. Connon, Chem.–Eur. J., 2006, 12, 5419; (g) T. Marcelli,
J. H. van Maarseveen and H. Hiemstra, Angew. Chem., Int. Ed.,
2006, 45, 7496; (h) E. A. Colby, Davie, S. M. Mennen, Y. Xu and
S. J. Miller, Chem. Rev., 2007, 107, 5759; (i) B. List, Chem. Rev.,
2007, 107, 5413; (j) A. G. Doyle and E. N. Jacobsen, Chem. Rev.,
2007, 107, 5713; (k) D. Almasi, D. A. Alonso and C. Najera,
Tetrahedron: Asymmetry, 2007, 18, 299; (l) S. B. Tsogoeva, Eur. J.
Org. Chem., 2007, 1701; (m) T. Akiyama, Chem. Rev., 2007, 107,
5744; (n) X.-H. Yu and W. Wang, Chem.–Asian J., 2008, 3, 1701.
13 See ESIw for details.
Notes and references
1 For reviews on applications of fluorinated compounds in medicinal
chemistry and drug discovery, see: (a) Biomedical Frontiers of
Fluorine Chemistry, ed. I. Ojima, J. R. McCarthy and
J. T. Welch, ACS, Washington DC, 1996; (b) P. Kirsch, Modern
Fluoroorganic Chemistry, Wiley-VCH, Weinheim, 2004;
(c) K. Muller, C. Faeh and F. Diederich, Science, 2007, 317,
1881; (d) K. L. Kirk, Org. Process Res. Dev., 2008, 12, 305.
2 (a) A. M. Thayer, Chem. Eng. News, 2006, 84, 15;
(b) A. M. Thayer, Chem. Eng. News, 2006, 84, 27.
14 D1-Pyrrolidines are useful building blocks in organic synthesis, see:
(a) B. D. Stubbert and T. J. Marks, J. Am. Chem. Soc., 2007, 129,
4253; (b) J. M. Carney, P. J. Donoghue, W. M. Wuest, O. Wiest
and P. Helquist, Org. Lett., 2008, 10, 3903.
ꢀc
This journal is The Royal Society of Chemistry 2009
2138 | Chem. Commun., 2009, 2136–2138